Motus GI Completes Enrollment in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients with a History of Poor Bowel Preparation
April 21, 2022 08:00 ET
|
Motus GI Holdings, Inc.
Topline data expected to be presented at a scientific conference in May 2022Independent data shows ~5.4M outpatient colonoscopies are performed in EU annually1New study data expected to further aid in...
Motus GI Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
March 29, 2022 16:05 ET
|
Motus GI Holdings, Inc.
Received FDA clearance in February 2022 to market Pure-Vu EVS, an all new, next-generation system that has been deployed to multiple hospitals in the first few weeks since launch Doubled the size of...
Motus GI to Release Fourth Quarter and Full Year 2021 Results and Provide a Business Update on March 29
March 15, 2022 16:05 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI to Participate in Two Upcoming Investor Conferences in March 2022
March 02, 2022 16:05 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., March 02, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that...
Motus GI Granted 180-Day Extension to Meet NASDAQ Minimum Bid Price Requirement
February 24, 2022 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System
February 14, 2022 06:30 ET
|
Motus GI Holdings, Inc.
-All New Pure-Vu EVS offers rapid set-up, improved navigation and enhanced cleansing capabilities to support expanded clinical utilization -Scientific literature shows ~51% of hospitalized inpatient...
Motus GI to Host Innovation Day Highlighting the Pure-Vu EVS System
January 20, 2022 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI Announces U.S. Patent For The Pure-Vu® System's Automatic Self-Purging Features
December 16, 2021 08:30 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI to Present at Two Upcoming Investor Conferences in December 2021
November 23, 2021 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that...
Motus GI Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 12, 2021 08:00 ET
|
Motus GI Holdings, Inc.
Reported approximately 40% increase in revenue compared to Q2 2021On track to file a 510(k) submission to FDA by end of 2021 for Pure-Vu EVS, an advanced, next-generation system that will enhance...